Mucositis

A painful inflammatory condition affecting mucous membranes, most commonly occurring as a side effect of cancer treatments, causing mouth ulcers and difficulty eating

Quick Facts

  • Type: Inflammatory Condition
  • ICD-10: K12.30
  • Urgency: Requires Medical Management
  • Duration: Varies with treatment

Overview

Mucositis is a painful inflammatory condition that affects the mucous membranes lining the mouth, throat, and digestive tract. This condition is characterized by inflammation, ulceration, and severe pain that can significantly impact a patient's quality of life, ability to eat, drink, and speak. While mucositis can occur in various clinical contexts, it is most commonly encountered as a side effect of cancer treatments, particularly chemotherapy and radiation therapy.

The mucous membranes serve as protective barriers and are composed of rapidly dividing cells that are particularly vulnerable to damage from cytotoxic treatments. When these cells are damaged faster than they can be repaired and replaced, the protective mucous lining breaks down, leading to inflammation, ulceration, and exposure of sensitive underlying tissues. This process creates an environment that is painful and susceptible to secondary infections.

Mucositis can be classified into several types based on the location affected. Oral mucositis affects the mouth and is the most common and well-studied form, occurring in up to 80% of patients receiving high-dose chemotherapy or head and neck radiation. Gastrointestinal mucositis affects the lining of the digestive tract from the esophagus to the colon and can cause symptoms ranging from throat pain to severe diarrhea. The severity of mucositis is typically graded on a scale from 1 to 4, with grade 4 being the most severe.

The impact of mucositis extends beyond physical discomfort. Severe cases can lead to treatment delays or dose reductions in cancer therapy, potentially affecting treatment outcomes. The condition can also result in increased healthcare costs due to extended hospital stays, nutritional support requirements, and management of secondary complications such as infections. Understanding and effectively managing mucositis is therefore crucial for maintaining treatment schedules and improving patient outcomes during cancer care.

Symptoms

Mucositis symptoms typically develop gradually over several days to weeks after treatment initiation and can vary significantly in severity and presentation.

Primary Symptoms

Early Stage Symptoms (Grade 1)

Mild Mucositis

  • Mild erythema: Slight redness of oral tissues
  • Oral sensitivity: Increased sensitivity to hot, cold, or spicy foods
  • Slight discomfort: Minor pain when eating or drinking
  • Dry mouth: Reduced saliva production
  • Altered taste: Changes in taste perception
  • Mild soreness: Tender areas in mouth or throat

Progressive Symptoms (Grade 2)

Moderate Mucositis

  • Patchy ulcerations: Small, scattered open sores
  • Moderate pain: Discomfort that may require pain medication
  • Difficulty with solids: Pain when eating solid foods
  • Tongue lesions: Sores and irritation on tongue surface
  • Gum inflammation: Red, swollen, tender gums
  • Increased saliva: Excessive drooling in some cases
  • Mild fever: Low-grade temperature elevation

Severe Symptoms (Grade 3-4)

Severe Mucositis

  • Confluent ulcerations: Large, merged areas of tissue breakdown
  • Severe pain: Intense pain requiring strong pain medications
  • Inability to eat solids: Can only tolerate liquids or nothing by mouth
  • Difficulty swallowing: Painful or impossible swallowing
  • Speech difficulties: Pain affecting ability to talk clearly
  • Bleeding: Spontaneous bleeding from ulcerated areas
  • Secondary infections: Bacterial, viral, or fungal overgrowth

Oral Cavity Symptoms

Mouth and Lip Involvement

  • Lip ulceration: Painful sores on lips, especially at corners
  • Cracked lips: Dry, fissured lip surface
  • Swollen lips: Inflammation causing lip enlargement
  • Burning sensation: Intense burning feeling in mouth
  • Metallic taste: Persistent unpleasant taste
  • Loss of taste: Reduced or absent taste sensation

Tongue and Gum Problems

  • Tongue lesions: Multiple ulcers on tongue surface and sides
  • Swollen tongue: Enlarged, tender tongue
  • White patches: Thrush or bacterial overgrowth
  • Geographic tongue: Map-like pattern of irritated areas
  • Bleeding gums: Spontaneous or traumatic bleeding
  • Gum recession: Pulling back of gum tissue

Throat and Swallowing Symptoms

Pharyngeal Involvement

  • Sore throat: Persistent, severe throat pain
  • Throat ulcers: Open sores in throat area
  • Difficulty swallowing liquids: Pain even with water
  • Feeling of throat closing: Sensation of constriction
  • Painful swallowing: Odynophagia with each swallow
  • Regurgitation: Food coming back up due to pain

Voice and Speech Changes

  • Hoarse voice: Rough, raspy vocal quality
  • Reduced voice volume: Difficulty speaking loudly
  • Speech avoidance: Reluctance to talk due to pain
  • Articulation problems: Difficulty forming words clearly
  • Voice fatigue: Tiredness from minimal speaking

Nutritional and Feeding Symptoms

Eating Difficulties

  • Decreased appetite: Significant reduction in food intake
  • Food aversion: Avoidance of previously enjoyed foods
  • Rapid satiety: Feeling full after small amounts
  • Nausea with eating: Stomach upset triggered by food
  • Vomiting: Due to pain or nausea
  • Weight loss: Significant, unintentional weight reduction

Specific Food Reactions

  • Citrus sensitivity: Severe pain with acidic foods
  • Spice intolerance: Cannot tolerate any seasoning
  • Temperature sensitivity: Pain with hot or cold foods
  • Texture problems: Difficulty with rough or hard foods
  • Salt sensitivity: Increased pain with salty foods

Systemic Symptoms

Constitutional Symptoms

  • Fever: Often low-grade, may spike with infections
  • Fatigue: Excessive tiredness and weakness
  • Dehydration: From reduced fluid intake
  • Malnutrition: From inadequate food consumption
  • Sleep disturbances: Pain interfering with rest
  • Mood changes: Irritability, depression, anxiety

Complications Symptoms

  • Secondary infections: Bacterial, viral, or fungal overgrowth
  • Sepsis signs: High fever, chills, rapid heart rate
  • Electrolyte imbalances: From dehydration and poor intake
  • Protein deficiency: Muscle wasting, slow healing
  • Vitamin deficiencies: Various nutritional deficits

Age-Specific Presentations

Pediatric Symptoms

  • Irritable infant: Excessive crying and fussiness
  • Feeding refusal: Complete rejection of food or bottle
  • Developmental regression: Loss of previously acquired skills
  • Sleep pattern changes: Frequent waking, difficulty settling
  • Behavioral changes: Increased clinginess or withdrawal
  • Growth delays: Failure to gain weight appropriately

Adult Symptoms

  • Work disability: Unable to perform job duties
  • Social isolation: Avoiding social eating situations
  • Communication barriers: Difficulty with phone calls, meetings
  • Treatment compliance issues: May want to stop cancer therapy
  • Quality of life impact: Significant functional impairment

Gastrointestinal Mucositis Symptoms

Upper GI Tract

  • Esophageal pain: Chest pain, heartburn-like symptoms
  • Stomach pain: Epigastric discomfort or burning
  • Nausea and vomiting: Persistent GI upset
  • Early satiety: Feeling full quickly
  • Gastric bleeding: Coffee-ground vomit or dark stools

Lower GI Tract

  • Abdominal cramping: Severe intestinal pain
  • Diarrhea: Frequent, watery bowel movements
  • Bloody stools: Blood in bowel movements
  • Anal pain: Discomfort around rectal area
  • Incontinence: Loss of bowel control

Grading System Recognition

WHO/NCI Grading Scale

  • Grade 0: No symptoms
  • Grade 1: Mild symptoms, normal diet possible
  • Grade 2: Moderate symptoms, soft diet required
  • Grade 3: Severe symptoms, liquid diet only
  • Grade 4: Life-threatening, unable to eat or drink

Warning Signs and Red Flags

Seek immediate medical attention for:

  • High fever: Temperature >101.3°F (38.5°C)
  • Signs of dehydration: Dizziness, dark urine, dry mouth
  • Inability to swallow: Cannot take liquids for >24 hours
  • Severe bleeding: Continuous bleeding from mouth
  • Signs of infection: Pus, spreading redness, systemic illness
  • Respiratory symptoms: Shortness of breath, chest pain
  • Neurological changes: Confusion, altered consciousness
  • Severe dehydration: Significant weight loss, reduced urination

Functional Impact Assessment

Activities of Daily Living

  • Eating independence: Ability to feed oneself
  • Communication ability: Can speak clearly and comfortably
  • Sleep quality: Restful sleep without pain interruption
  • Work capacity: Ability to perform job functions
  • Social functioning: Participation in social activities
  • Self-care ability: Oral hygiene, grooming independence

Causes

Mucositis develops when the protective mucous membrane lining becomes damaged faster than it can repair itself, leading to inflammation and ulceration.

Cancer Treatment-Related Causes

Chemotherapy

  • Cytotoxic agents: Drugs that damage rapidly dividing cells
  • High-dose regimens: Intensive treatment protocols
  • Combination therapies: Multiple chemotherapy drugs together
  • Methotrexate: Antimetabolite particularly associated with mucositis
  • 5-Fluorouracil: Commonly causes oral and GI mucositis
  • Doxorubicin: Anthracycline with mucotoxic effects

Radiation Therapy

  • Head and neck radiation: Direct exposure to oral cavity
  • Total body irradiation: Before bone marrow transplant
  • Abdominal radiation: Affecting GI tract mucosa
  • High-dose radiation: Increased severity with higher doses
  • Fractionated treatments: Cumulative damage over time
  • Concurrent chemoradiation: Combined therapy increases risk

Targeted Therapies

  • mTOR inhibitors: Everolimus, sirolimus
  • EGFR inhibitors: Cetuximab, panitumumab
  • Multi-kinase inhibitors: Sunitinib, sorafenib
  • Proteasome inhibitors: Bortezomib
  • Immunotherapy agents: Some checkpoint inhibitors

Stem Cell Transplantation

Pre-transplant Conditioning

  • High-dose chemotherapy: Ablative regimens
  • Total body irradiation: Preparation for transplant
  • Busulfan-based regimens: Alkylating agent conditioning
  • Melphalan conditioning: High-dose alkylating therapy

Post-transplant Factors

  • Graft-versus-host disease: Immune reaction affecting mucosa
  • Immunosuppressive drugs: Methotrexate, cyclosporine
  • Opportunistic infections: Viral, bacterial, fungal
  • Engraftment syndrome: Inflammatory response

Pathophysiological Mechanisms

Direct Cytotoxicity

  • DNA damage: Direct injury to rapidly dividing cells
  • Cell cycle disruption: Interference with normal cell division
  • Apoptosis induction: Programmed cell death
  • Mitotic catastrophe: Failed cell division attempts

Inflammatory Response

  • Cytokine release: Pro-inflammatory mediators
  • Nuclear factor activation: NF-κB pathway
  • Complement activation: Immune system response
  • Oxidative stress: Free radical damage

Contributing Risk Factors

Patient-Related Factors

  • Age extremes: Very young or elderly patients
  • Female gender: Higher risk in women
  • Poor oral health: Pre-existing dental problems
  • Nutritional status: Malnutrition increases risk
  • Genetic polymorphisms: Individual susceptibility variations
  • Immunocompromised state: Reduced ability to heal

Treatment-Related Factors

  • Dose intensity: Higher doses increase risk
  • Treatment duration: Prolonged exposure
  • Drug combinations: Synergistic toxic effects
  • Previous treatments: Prior chemotherapy or radiation
  • Concurrent medications: Drug interactions

Secondary Causes

Infectious Agents

  • Herpes simplex virus: Reactivation during immunosuppression
  • Cytomegalovirus: Opportunistic viral infection
  • Candida species: Fungal overgrowth
  • Bacterial infections: Gram-positive and gram-negative
  • Epstein-Barr virus: Reactivation in immunocompromised

Mechanical Trauma

  • Dental procedures: Extractions, cleanings
  • Ill-fitting dentures: Chronic irritation
  • Aggressive oral hygiene: Traumatic brushing
  • Intubation trauma: From medical procedures
  • Food-related injury: Hard, sharp, or hot foods

Non-Cancer Related Causes

Autoimmune Conditions

  • Behçet's disease: Recurrent oral and genital ulcers
  • Crohn's disease: Inflammatory bowel disease
  • Systemic lupus erythematosus: Autoimmune disorder
  • Pemphigus and pemphigoid: Blistering disorders
  • Lichen planus: Chronic inflammatory condition

Medications (Non-chemotherapy)

  • Immunosuppressants: Methotrexate for autoimmune diseases
  • Anticonvulsants: Phenytoin
  • Antibiotics: Long-term or broad-spectrum use
  • NSAIDs: Chronic use causing GI mucosal damage
  • Bisphosphonates: Osteonecrosis-related mucositis

Environmental and Lifestyle Factors

Nutritional Deficiencies

  • Vitamin deficiencies: B12, folate, vitamin C
  • Mineral deficiencies: Iron, zinc
  • Protein malnutrition: Impaired healing capacity
  • Dehydration: Reduced mucous membrane integrity

Habits and Exposures

  • Tobacco use: Smoking or chewing tobacco
  • Alcohol consumption: Chronic heavy drinking
  • Spicy foods: Chronic irritation
  • Chemical exposure: Industrial or household chemicals
  • Poor oral hygiene: Bacterial overgrowth

Predisposing Medical Conditions

Systemic Diseases

  • Diabetes mellitus: Impaired healing and increased infection risk
  • Renal disease: Uremic toxins affecting mucosa
  • Liver disease: Altered drug metabolism
  • Cardiovascular disease: Reduced tissue perfusion
  • Respiratory disease: Mouth breathing, dry mucosa

Hematologic Conditions

  • Neutropenia: Reduced immune response
  • Thrombocytopenia: Increased bleeding risk
  • Anemia: Reduced tissue oxygenation
  • Coagulation disorders: Bleeding complications

Timing and Development Patterns

Acute Mucositis

  • Onset timing: 3-10 days after treatment start
  • Peak severity: 1-2 weeks after treatment
  • Resolution: 2-4 weeks after treatment completion
  • Predictable pattern: Follows treatment cycles

Chronic Mucositis

  • Persistent inflammation: Lasting >3 months
  • Recurrent episodes: Cyclical flare-ups
  • Progressive worsening: Cumulative damage
  • Treatment resistance: Difficult to manage

Risk Factors

Multiple factors can increase the likelihood and severity of developing mucositis:

Treatment-Related Risk Factors

  • High-dose chemotherapy: Increased drug concentration
  • Radiation to head/neck: Direct mucosal exposure
  • Stem cell transplantation: Intensive conditioning regimens
  • Combination therapy: Multiple treatment modalities
  • Previous cancer treatment: Prior chemotherapy or radiation
  • Concurrent treatments: Multiple drugs simultaneously

Patient Demographics

  • Age extremes: Children and elderly patients
  • Female gender: Higher risk in women
  • Genetic factors: Inherited susceptibility
  • Race/ethnicity: Some populations at higher risk

Health Status Factors

  • Poor oral health: Dental disease, gum problems
  • Malnutrition: Inadequate protein, vitamins
  • Immunocompromised state: Reduced immune function
  • Dehydration: Inadequate fluid intake
  • Chronic medical conditions: Diabetes, autoimmune diseases

Lifestyle Risk Factors

  • Tobacco use
  • Alcohol consumption
  • Poor oral hygiene
  • Inadequate nutrition
  • High stress levels

Diagnosis

Mucositis diagnosis is primarily clinical, based on patient history, symptoms, and physical examination findings.

Clinical Assessment

Patient History

  • Treatment history: Recent chemotherapy, radiation, or other treatments
  • Symptom timeline: Onset, progression, severity
  • Pain assessment: Location, intensity, triggers
  • Functional impact: Eating, drinking, speaking abilities
  • Associated symptoms: Fever, difficulty swallowing
  • Previous episodes: History of mucositis

Physical Examination

  • Oral cavity inspection: Visualization of mouth, tongue, throat
  • Ulcer assessment: Size, depth, location of sores
  • Inflammation evaluation: Redness, swelling
  • Hydration status: Signs of dehydration
  • Nutritional assessment: Weight loss, muscle wasting
  • Infection signs: Pus, unusual discharge

Severity Grading

WHO Oral Toxicity Scale

  • Grade 0: No oral toxicity
  • Grade 1: Oral soreness, erythema
  • Grade 2: Oral erythema, ulcers, solid diet tolerated
  • Grade 3: Oral ulcers, liquid diet only
  • Grade 4: Oral alimentation impossible

NCI Common Terminology Criteria

  • Grade 1: Asymptomatic or mild symptoms
  • Grade 2: Moderate pain, modified diet
  • Grade 3: Severe pain, inability to eat solids
  • Grade 4: Life-threatening, urgent intervention needed
  • Grade 5: Death related to adverse event

Diagnostic Tests

Laboratory Studies

  • Complete blood count: Check for neutropenia, anemia
  • Comprehensive metabolic panel: Electrolytes, kidney function
  • Inflammatory markers: ESR, CRP if infection suspected
  • Nutritional markers: Albumin, prealbumin
  • Vitamin levels: B12, folate, vitamin D

Microbiological Testing

  • Bacterial cultures: If secondary infection suspected
  • Viral testing: HSV, CMV PCR
  • Fungal cultures: Candida, other yeasts
  • Sensitivity testing: Antibiotic resistance patterns

Imaging Studies

  • Not routinely needed: Diagnosis is clinical
  • CT scan: If deep tissue involvement suspected
  • MRI: For complex cases with unclear extent
  • Upper endoscopy: For severe GI mucositis

Differential Diagnosis

  • Viral stomatitis (HSV, CMV)
  • Bacterial infections
  • Fungal infections (candidiasis)
  • Aphthous ulcers
  • Autoimmune conditions
  • Drug-induced oral lesions
  • Oral malignancy
  • Nutritional deficiencies

Treatment Options

Treatment of mucositis focuses on pain management, maintaining nutrition, preventing complications, and supporting healing.

Pain Management

Topical Analgesics

  • Lidocaine solutions: Viscous lidocaine for numbing
  • Benzocaine preparations: Over-the-counter numbing agents
  • Dyclonine hydrochloride: Topical anesthetic solution
  • Magic mouthwash: Compound solutions with multiple agents
  • Coating agents: Sucralfate suspension

Systemic Pain Relief

  • NSAIDs: For mild to moderate pain
  • Acetaminophen: Safe first-line option
  • Opioid analgesics: For severe pain
  • Patient-controlled analgesia: For hospitalized patients
  • Gabapentin: For neuropathic pain component

Oral Care and Hygiene

Basic Oral Hygiene

  • Gentle brushing: Soft-bristled toothbrush
  • Saline rinses: Multiple times daily
  • Alcohol-free mouthwash: Avoid irritating ingredients
  • Frequent mouth care: Every 2-4 hours while awake
  • Lip care: Petroleum jelly or lip balm

Therapeutic Rinses

  • Sodium bicarbonate: Alkaline environment
  • Chlorhexidine: Antimicrobial rinse (with caution)
  • Hydrogen peroxide: Diluted solutions for cleaning
  • Specialized formulations: Commercial mucositis rinses

Nutritional Support

Dietary Modifications

  • Soft, bland foods: Easy to swallow options
  • Cold foods: Ice cream, smoothies, popsicles
  • Liquid nutrition: Protein shakes, nutritional supplements
  • Avoid irritants: Spicy, acidic, rough foods
  • Small, frequent meals: Better tolerance

Advanced Nutritional Support

  • Enteral nutrition: Feeding tubes if needed
  • Parenteral nutrition: IV nutrition for severe cases
  • Vitamin supplementation: B-complex, vitamin C
  • Mineral supplements: Zinc, iron as needed
  • Hydration support: IV fluids if dehydrated

Specific Therapeutic Agents

Mucosal Protectants

  • Sucralfate: Forms protective barrier
  • Gelclair: Bioadherent oral gel
  • MuGard: Oral rinse forming protective coating
  • Caphosol: Electrolyte rinse

Growth Factors and Cytokines

  • Palifermin (KGF): Keratinocyte growth factor
  • GM-CSF: Granulocyte-macrophage colony stimulating factor
  • Indication: High-risk patients undergoing intensive therapy

Infection Prevention and Treatment

Antifungal Therapy

  • Nystatin: Topical antifungal for thrush
  • Fluconazole: Systemic antifungal
  • Clotrimazole troches: Dissolvable antifungal
  • Amphotericin B: For refractory fungal infections

Antiviral Therapy

  • Acyclovir: For HSV infections
  • Valacyclovir: Oral prodrug of acyclovir
  • Ganciclovir: For CMV infections
  • Prophylactic use: In high-risk patients

Bacterial Infection Treatment

  • Targeted antibiotics: Based on culture results
  • Broad-spectrum coverage: For severe infections
  • Topical antibiotics: For localized infections

Advanced and Experimental Therapies

Photobiomodulation

  • Low-level laser therapy: Promotes healing
  • LED light therapy: Anti-inflammatory effects
  • Treatment protocol: Daily sessions during treatment

Other Emerging Therapies

  • Honey-based products: Natural antimicrobial
  • Probiotics: Restore normal flora
  • Stem cell therapy: Experimental approach
  • Immunomodulators: Research stage

Severe Cases Management

Hospitalization Indications

  • Grade 3-4 mucositis with dehydration
  • Inability to maintain oral intake
  • Secondary infections requiring IV antibiotics
  • Severe pain requiring parenteral analgesics
  • Electrolyte imbalances

Intensive Support Measures

  • IV hydration: Correct dehydration
  • Nutritional support: Enteral or parenteral
  • Pain management: PCA pumps, continuous infusions
  • Infection control: Broad-spectrum antibiotics
  • Electrolyte correction: Monitor and replace as needed

Treatment Monitoring

  • Daily symptom assessment: Pain scores, functional status
  • Weight monitoring: Track nutritional status
  • Oral examination: Grade severity changes
  • Laboratory monitoring: Electrolytes, nutrition markers
  • Infection surveillance: Cultures if indicated

Prevention

While mucositis cannot always be prevented, its severity can often be reduced through proactive measures.

Pre-treatment Preparation

  • Dental evaluation: Complete dental care before treatment
  • Nutritional optimization: Improve nutritional status
  • Oral hygiene education: Proper care techniques
  • Baseline assessment: Document oral health status
  • Risk factor modification: Smoking cessation, alcohol reduction

During Treatment

  • Excellent oral hygiene: Gentle, frequent care
  • Saline rinses: Multiple times daily
  • Avoid irritants: Alcohol, tobacco, spicy foods
  • Stay hydrated: Adequate fluid intake
  • Soft diet: Avoid trauma from hard foods
  • Regular monitoring: Early detection of problems

Prophylactic Measures

  • Palifermin: For high-risk stem cell transplant patients
  • Cryotherapy: Ice chips during certain chemotherapy
  • Low-level laser therapy: Preventive photobiomodulation
  • Protective mouthwashes: Specialized formulations

Lifestyle Modifications

  • Maintain excellent oral hygiene
  • Follow a balanced, nutritious diet
  • Stay well-hydrated
  • Avoid tobacco and limit alcohol
  • Manage stress effectively
  • Get adequate rest and sleep

When to See a Doctor

Patients undergoing cancer treatment should maintain regular contact with their healthcare team about oral symptoms.

Immediate Medical Attention

  • High fever: Temperature >101.3°F (38.5°C)
  • Unable to swallow: Cannot take liquids for >24 hours
  • Signs of dehydration: Dizziness, decreased urination
  • Severe bleeding: Continuous bleeding from mouth
  • Difficulty breathing: Throat swelling affecting airway
  • Signs of systemic infection: Chills, confusion
  • Severe pain: Uncontrolled despite medication

Routine Medical Care

  • New mouth sores: Any ulcers or lesions
  • Worsening pain: Increasing severity
  • Eating difficulties: Cannot maintain nutrition
  • White patches: Possible fungal infection
  • Persistent symptoms: Not improving as expected
  • Weight loss: Significant or rapid loss

Follow-up Scheduling

  • Regular oncology appointments
  • Dental follow-up as recommended
  • Nutritionist consultation if needed
  • Pain management specialist if severe pain
  • Emergency contact information available

Frequently Asked Questions

How long does mucositis last?

The duration of mucositis varies depending on the treatment type and individual factors. Typically, symptoms begin 3-10 days after treatment starts, peak at 1-2 weeks, and resolve within 2-4 weeks after treatment completion. However, some patients may experience symptoms for several weeks longer, especially with intensive treatments like stem cell transplantation.

Can mucositis be prevented?

While mucositis cannot always be completely prevented, its severity can often be reduced. Preventive measures include maintaining excellent oral hygiene, optimizing nutrition before treatment, completing necessary dental work, and avoiding irritants like tobacco and alcohol. Some patients may benefit from preventive medications like palifermin or cryotherapy during specific treatments.

What foods should I avoid with mucositis?

Avoid foods that can irritate the mouth: spicy, acidic, or salty foods; rough or hard textures like chips or crusty bread; very hot foods and beverages; alcohol and tobacco products; and citrus fruits or tomatoes. Instead, focus on soft, bland, cool foods like smoothies, ice cream, yogurt, and lukewarm soups.

When should I contact my healthcare team about mouth sores?

Contact your healthcare team immediately for fever above 101.3°F (38.5°C), inability to swallow liquids for more than 24 hours, signs of dehydration, continuous bleeding from the mouth, or severe pain not controlled by prescribed medications. Also report any new mouth sores, white patches, or worsening symptoms during treatment.

Will mucositis affect my cancer treatment schedule?

Severe mucositis may require treatment delays or dose modifications to allow healing and prevent life-threatening complications. However, with proper management and supportive care, many patients can continue their treatment schedule. Your oncology team will work to balance effective cancer treatment with managing side effects to optimize your overall outcomes.